UMDNJ - New Jersey Med School / Cooper Hosp — Camden, New Jersey

UMDNJ - New Jersey Med School / Cooper Hosp is a clinical research site located in Camden, New Jersey, United States 08103.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

UMDNJ - New Jersey Med School / Cooper Hosp has participated in 5 clinical trials.

Therapeutic areas: Meningitis, Cryptococcal, HIV Infections, Mycobacterium Avium-intracellulare Infection.

Sponsors: InterMune, Hoffmann-La Roche, National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Camden

Browse all research sites in New Jersey · View every site in Camden

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UMDNJ - New Jersey Med School / Cooper Hosp?

UMDNJ - New Jersey Med School / Cooper Hosp has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UMDNJ - New Jersey Med School / Cooper Hosp conducted?

UMDNJ - New Jersey Med School / Cooper Hosp has 5 clinical trials on record. Their work covers Meningitis, Cryptococcal, HIV Infections, Mycobacterium Avium-intracellulare Infection.

Is UMDNJ - New Jersey Med School / Cooper Hosp accredited by Crixeo Clinical Trials?

UMDNJ - New Jersey Med School / Cooper Hosp has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UMDNJ - New Jersey Med School / Cooper Hosp?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.